Diabetes, cardiovascular disease and the microcirculation

Abstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which i...

Full description

Bibliographic Details
Main Authors: W. David Strain, P. M. Paldánius
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12933-018-0703-2
id doaj-b7abcbf2837b42b793aad816fce9a7e2
record_format Article
spelling doaj-b7abcbf2837b42b793aad816fce9a7e22020-11-24T21:45:44ZengBMCCardiovascular Diabetology1475-28402018-04-0117111010.1186/s12933-018-0703-2Diabetes, cardiovascular disease and the microcirculationW. David Strain0P. M. Paldánius1Diabetes and Vascular Medicine Research Centre, NIHR Exeter Clinical Research Facility and Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation TrustNovartis Pharma AGAbstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which is substantially more frequent than would be anticipated based on general population samples. The impact of hypertension is considerably higher in people with diabetes than it is in the general population, suggesting either an increased sensitivity to its effect or a confounding underlying aetiopathogenic mechanism of hypertension associated with CVD within diabetes. In this contribution, we aim to review the changes observed in the vascular tree in people with T2DM compared to the general population, the effects of established anti-diabetes drugs on microvascular outcomes, and explore the hypotheses to account for common causalities of the increased prevalence of CVD and hypertension in people with T2DM.http://link.springer.com/article/10.1186/s12933-018-0703-2MicrocirculationType 2 diabetes mellitusHypertensionCardiovascular diseaseMicrovascular changesMicroalbuminuria
collection DOAJ
language English
format Article
sources DOAJ
author W. David Strain
P. M. Paldánius
spellingShingle W. David Strain
P. M. Paldánius
Diabetes, cardiovascular disease and the microcirculation
Cardiovascular Diabetology
Microcirculation
Type 2 diabetes mellitus
Hypertension
Cardiovascular disease
Microvascular changes
Microalbuminuria
author_facet W. David Strain
P. M. Paldánius
author_sort W. David Strain
title Diabetes, cardiovascular disease and the microcirculation
title_short Diabetes, cardiovascular disease and the microcirculation
title_full Diabetes, cardiovascular disease and the microcirculation
title_fullStr Diabetes, cardiovascular disease and the microcirculation
title_full_unstemmed Diabetes, cardiovascular disease and the microcirculation
title_sort diabetes, cardiovascular disease and the microcirculation
publisher BMC
series Cardiovascular Diabetology
issn 1475-2840
publishDate 2018-04-01
description Abstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which is substantially more frequent than would be anticipated based on general population samples. The impact of hypertension is considerably higher in people with diabetes than it is in the general population, suggesting either an increased sensitivity to its effect or a confounding underlying aetiopathogenic mechanism of hypertension associated with CVD within diabetes. In this contribution, we aim to review the changes observed in the vascular tree in people with T2DM compared to the general population, the effects of established anti-diabetes drugs on microvascular outcomes, and explore the hypotheses to account for common causalities of the increased prevalence of CVD and hypertension in people with T2DM.
topic Microcirculation
Type 2 diabetes mellitus
Hypertension
Cardiovascular disease
Microvascular changes
Microalbuminuria
url http://link.springer.com/article/10.1186/s12933-018-0703-2
work_keys_str_mv AT wdavidstrain diabetescardiovasculardiseaseandthemicrocirculation
AT pmpaldanius diabetescardiovasculardiseaseandthemicrocirculation
_version_ 1725904568534958080